Wanat MA, Hart SR, Putney D, Liebl M, Chandler WL. Alternative monitoring of argatroban with plasma-diluted thrombin time. Ann Pharmacother 2013 Mar 12. [Epub ahead of print].

Wanat MA. Novel oral anticoagulants: a review of new agents. Postgrad Med 2013. [Accepted for publication January 2013].

Wanat MA, Fitousis K, Bostan F, Masud F. Comparison of Dexmedetomidine versus propofol for sedation in mechanically ventilated patients after cardiovascular surgery. Methodist Debakey Cardiovasc J 2013. [Accepted for publication March 2013]

Wanat MA, Fitousis K, Hall J, Rice L. PF4/Heparin antibody testing and treatment of heparin-induced thrombocytopenia in the ICU. Clin Appl Thromb Hemost. 2012 March [epub ahead of print]

Wanat MA, Nguyen P, Tebbe S. Heparin-Induced Thrombocytopenia: Recognition, Treatment and the Pharmacist Role. TSHP 2011; 12:14-19.

Wanat MA. The Last Xigris®. Gulf-Coast Society of Health-System Pharmacists. December/January 2012 Newsletter.

TMH Pharmacy and Therapeutics News. The Methodist Hospital, Houston, TX. May 2010, Volume 4, Issue 5.

TMH Pharmacy and Therapeutics News. The Methodist Hospital, Houston, TX. April 2010, Volume 4, Issue 4.

Cost-effectiveness analysis of dexmedetomidine versus propofol for sedation in mechanically ventilated patients after cardiovascular surgery: an institutional perspective, poster presentation, American College of Clinical Pharmacy, 2012 Virtual Poster Symposium, May 2012

Pharmacy implications with enteral nutrition Pharmacy OneSource, live Online Webinar, Wolters Kluwer Health, April 2012

Comparison of dexmedetomidine versus propofol for sedation in intensive care unit patients after coronary artery bypass or valve surgery, poster presentation, University Healthsystem Consortium Meeting 2011 at ASHP Midyear, New Orleans, LA, December 2011

Enoxaparin dosing and anti-xa levels in medically-ill, morbidly obese patients, poster presentation, University Healthsystem Consortium Meeting 2011 at ASHP Midyear, New Orleans, LA, December 2011

ACPE Accredited Presentation (1.0 CEU): Pharmacy implications with enteral nutrition, The Methodist Hospital, Houston, TX, October 2011

Ordering of heparin PF-4 antibodies and treatment of heparin-induced thrombocytopenia in the ICU, poster presentation, International Society of Thrombosis and Haemostasis 2011, Kyoto, Japan, July 2011

Ordering of heparin PF-4 antibodies and treatment of heparin-induced thrombocytopenia in the ICU, platform presentation, Midwest Regional Pharmacy Residents Conference, Omaha, NE, May 2011; Quality and Safety 2014 Symposium, Houston, TX, April 2011; Alcalde Leadership Conference, San Antonio, TX, April 2011

ACPE Accredited Presentation (1.0 CEU): Treatment of venous thromboembolism, The Methodist Hospital, Houston, TX, April 2011

Characterizing heparin-induced thrombocytopenia in the ICU, poster presentation, American Society of Health System Pharmacists Meeting 2010, Anaheim, CA, December 2010

An Inventory of the scholarship of assessment, learning and teaching at Northeastern University, poster presentation, American Association of the Colleges of Pharmacy Meeting 2010, Seattle, WA, July 2010

Cost-effectiveness of aliskiren versus lisinopril as treatment in mild to moderate hypertensive patients in the reduction of blood pressure over eight weeks: A third-party payer perspective, poster presentation, American Society of Health-System Pharmacists Meeting 2009, Las Vegas, NV, December 2009

An Evidence-based algorithm for evaluating QTc-related drug Interaction alerts, poster presentation, American Medical Informatics Spring Symposium 2007, Chicago, IL, April 2007

Pathophysiology and treatment of hepatorenal syndrome, presentation, Pharmacy Forum, The Methodist Hospital, Houston, TX, February 2012

Surgery residents ABSITE board review: pharmacy review, invited presentation, Department of Surgery, The Methodist Hospital, Houston, TX, January 2012

Pulmonary physiology and ARDS (Recurring for 2011-12 year), ICU student lecture, The Methodist Hospital, Houston, TX, January 2012 – June 2012

Use of tPA in emergency situations, invited presentation, ED Physicians Meeting, The Methodist Hospital, Houston, TX, September 2011

Treatment of venous thromboembolism (Recurring for 2011-12 academic year), ICU student lecture, The Methodist Hospital, Houston, TX, July 2011 – June 2012

A Review of vasopressors, nursing education presentation, The Methodist Hospital, Houston, TX, November 2010

Aztreonam inhaled (Cayston®): A novel inhaled therapy, invited lecture, Respiratory Care Fall Seminar 2010, The Methodist Hospital, Houston, TX, October 2010

Respiratory treatments in Cystic Fibrosis, presentation, Pharmacy Forum, The Methodist Hospital, Houston, TX, September 2010

Anticoagulation with fondaparinux (Arixtra®), nursing education presentation, VA Boston Pharmacy Department, Boston, MA, February 2010

The role of statins in preventing cerebral vasospasm, invited presentation, Clinical Pharmacy Meeting, Boston Medical Center, Boston, MA, October 2009

A Closer look at clopidogrel: triple therapy, drug interactions and future uses, invited presentation, Boston Healthcare for the Homeless Meeting, BHCHP, Boston, MA, October 2009

Ethylene glycol overdose, presentation, Clinical Pharmacy Meeting, Lahey Clinic, Burlington, MA, July 2009

Cost-effectiveness of aliskiren versus lisinopril as treatment in mild to moderate hypertensive patients in the reduction of blood pressure over eight weeks: A third-party payers perspective, Capstone Presentation, School of Pharmacy, Northeastern University, Boston, MA, April 2009